Jennifer A. Doudna
Co-Founder & Scientific AdvisorDr. Jennifer A. Doudna Ph.D., is Independent Director of Johnson & Johnson from April 26, 2018. Dr. Doudna joined the Johnson & Johnson on April 26, 2018. Dr. Doudna is Member of Scientific Advisory Board of Isomorphic Labs Limited. Dr. Doudna is Founder & Member of Scientific Advisor Board of Intellia Therapeutics, Inc. Dr. Doudna joined the Intellia Therapeutics, Inc. in April 2015. Dr. Doudna is Member of Clinical & Scientific Advisory Board of eFFECTOR Therapeutics, Inc. Dr. Doudna is Co-founder & Member of Scientific Advisory Board of Caribou Biosciences, Inc. Dr. Doudna was Member of Scientific Advisory Board of Caribou Biosciences, Inc. Dr. Doudna is Science Partner of The Column Group, LLC from 2026. Dr. Doudna was Ipartner of The Column Group, LLC until 2026. Dr. Doudna is Member of the Board of Advisors of Orchard Venture Partners. Dr. Doudna is Independent Director of Tempus AI, Inc. from April 2021. Dr. Doudna is Member of Scientific Strategy Board of Inari Agriculture, Inc. Dr. Doudna is Co-Founder & Chair of Scientific Advisory Board of Mammoth Biosciences, Inc. Dr. Doudna is Co-Founder & Scientific Advisor of Scribe Therapeutics Inc. Dr. Doudna is Member of Scientific Advisory Board of InvisiShield Technologies Ltd. from January 2023. Dr. Doudna is Advisor of BEVC Management, LLC. Dr. Doudna is Founder of Aurora Therapeutics, Inc. Dr. Doudna was Member of Advisory Board of Synthego Corporation. Dr. Doudna has Ph.D. in Biochemistry from Harvard University, Master's in Biomedical Science from University of Colorado, B.A. in Biochemistry from Pomona College, Master's in Genetics from Harvard Medical School.
Positions
- Company NameScribe Therapeutics Inc.Stock CodeSCTXPositionCo-Founder & Scientific AdvisorColleagues
- BLBenjamin L. OakesCo-Founder, President, CEO & Chairman
- DLDavid L. ParrotCFO & Treasurer
- SLSvetlana LucasChief Operating Officer
- JAJennifer A. DoudnaCo-Founder & Scientific Advisor
- BTBrett T. StaahlCo-Founder & VP of External Innovation
- JDJames Dean WatsonIndependent Director
- JBJoshua BleharskiLead Independent Director
- BABehzad AghazadehIndependent Director
- CLCarl Lee GordonIndependent Director
- Company NameeFFECTOR Therapeutics, Inc.Stock CodeEFTRPositionMember of Clinical & Scientific Advisory BoardColleagues
- DRDavide RuggeroCo-Founder and Member of Clinical & Scientific Advisory Board
- KMKevan M. ShokatCo-Founder and Member of Clinical & Scientific Advisory Board
- JSJoan S. BruggeMember of Clinical & Scientific Advisory Board
- JAJennifer A. DoudnaMember of Clinical & Scientific Advisory Board
- NRNeal RosenMember of Clinical & Scientific Advisory Board
- Company NameIntellia Therapeutics, Inc.Stock CodeNTLAPositionFounder & Member of Scientific Advisor BoardColleagues
- JMJohn M. LeonardPresident, CEO & Director
- FAFranciscus A. G. M. VerwielIndependent Chairman of the Board
- EJEdward J. DulacExecutive VP, CFO & Treasurer
- BSBirgit SchultesExecutive VP & Chief Scientific Officer
- JEJames E. BastaExecutive VP, General Counsel & Corporate Secretary
- RERachel E. HaurwitzCo-Founder
- DJDerrick J. RossiFounder & Member of Scientific Advisor Board
- RBRodolphe BarrangouFounder & Member of Scientific Advisor Board
- Company NameCaribou Biosciences, Inc.Stock CodeCRBUPositionCo-founder & Member of Scientific Advisory BoardColleagues
- RERachel E. HaurwitzCo-Founder, CEO, President & Director
- ALAndrew L. GuggenhimeIndependent Chairman
- SRSriram RyaliChief Financial Officer
- BGBarbara G. McClungChief Legal Officer & Corporate Secretary
- JAJennifer A. DoudnaCo-founder & Member of Scientific Advisory Board
- RFRyan FischesserInterim Principal Accounting Officer & Controller
- NSNatalie SacksIndependent Director
- SNScott N. BraunsteinIndependent Director
